Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
4.230
+0.260 (6.55%)
Nov 21, 2024, 1:34 PM EST - Market open
Company Description
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties.
The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Cibus, Inc. is based in San Diego, California.
Cibus, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 20, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 183 |
| CEO | Rory Riggs |
Contact Details
Address: 6455 Nancy Ridge Drive San Diego, California 92121 United States | |
| Phone | 858 450 0008 |
| Website | cibus.com |
Stock Details
| Ticker Symbol | CBUS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001705843 |
| CUSIP Number | 17166A101 |
| ISIN Number | US17166A1016 |
| Employer ID | 27-1967997 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Sean O'Connor Ph.D. | Senior Vice President and President and Chief Executive Officer of Nucelis |
| Rory Balfour Riggs M.B.A. | Co-Founder, Chief Executive Officer and Chairman |
| Dr. Peter Beetham B.Sc., Ph.D. | Co-Founder, President, Chief Operating Officer and Director |
| Dr. Greg Gocal Ph.D. | Co-Founder, Chief Scientific Officer and Executive Vice President |
| Jason Stokes J.D. | Chief Legal Officer, General Counsel and Corporate Secretary |
| Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Dr. James Radtke Ph.D. | Senior Vice President of Product Development |
| Tony Moran | Senior Vice President of International Development |
| Norm Sissons | Senior Vice President of Seed and Traits |
| Noel Sauer Ph.D. | Senior Vice President of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2024 | 8-K | Current Report |
| Nov 18, 2024 | 144 | Filing |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Nov 7, 2024 | 8-K | Current Report |
| Oct 30, 2024 | 8-K | Current Report |
| Oct 18, 2024 | 8-K | Current Report |
| Oct 1, 2024 | 8-K | Current Report |
| Sep 23, 2024 | 8-K | Current Report |
| Sep 19, 2024 | 8-K | Current Report |
| Sep 19, 2024 | 424B5 | Filing |